ALZN
Alzamend Neuro, Inc.$1.03-0.07 (-6.36%)Prev Close$1.10·MCap$6.8M·P/E—·Vol19.0K·Yield—
▲
Buys (12M)
1
$108.9K
▼
Sells (12M)
14
$2.23M
◆
Net Activity
Net Seller
$2.12M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Alzamend Neuro, Inc. (ALZN) has been dominated by selling, with 1 insider purchase totaling $108.9K and 14 insider sales totaling $2.23M. The most recent insider transaction was by AULT MILTON C III (director), who purchased $108.9K worth of shares on Apr 16, 2026. Alzamend Neuro, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $6.8M.
ALZN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | AULT MILTON C III | director | Buy | 108,388 | $1.00 | $108.9K3.5% OS | 116,648New Position |
| Dec 23, 2025 | AULT MILTON C III | Director | Sell | 1,851 | $2.07 | $3.8K | 0 |
| Dec 19, 2025 | Horne William B. | Director | Sell | 3,333 | $2.12 | $7.1K | 0 |
| Oct 23, 2025 | McGrath Lynne Fahey | Director | Sell | 30 | $2.29 | $68.70 | 0 |
| Oct 8, 2025 | AULT MILTON C III | Director | Sell | 121,791 | $2.42 | $294.5K3.9% OS | 0 |
| Oct 3, 2025 | AULT MILTON C III | Director | Sell | 139,412 | $2.47 | $344.2K4.4% OS | 0 |
| Oct 1, 2025 | AULT MILTON C III | Director | Sell | 123,366 | $2.41 | $296.8K3.9% OS | 0 |
| Sep 26, 2025 | AULT MILTON C III | Director | Sell | 79,628 | $2.31 | $184.2K2.5% OS | 0 |
| Sep 23, 2025 | AULT MILTON C III | Director | Sell | 97,006 | $2.34 | $226.9K3.1% OS | 0 |
| Sep 19, 2025 | AULT MILTON C III | Director | Sell | 77,009 | $2.35 | $180.9K2.5% OS | 0 |
| Sep 17, 2025 | AULT MILTON C III | Director | Sell | 22,991 | $2.47 | $56.7K0.7% OS | 0 |
| Jul 30, 2025 | AULT MILTON C III | Director | Sell | 129,449 | $2.28 | $295.5K4.1% OS | 0 |
| Jul 25, 2025 | AULT MILTON C III | Director | Sell | 44,843 | $2.86 | $128.2K1.4% OS | 0 |
| Jul 23, 2025 | AULT MILTON C III | Director | Sell | 69,137 | $2.95 | $203.8K2.2% OS | 0 |
| May 12, 2025 | AULT MILTON C III | Director | Sell | 1,224 | $5.06 | $6.2K | 0 |
| Mar 26, 2025 | Horne William B. | Director | Buy | 3,334 | $0.99 | $3.3K | 0 |
| Mar 21, 2025 | AULT MILTON C III | Director | Buy | 2,905 | $1.02 | $3.0K | 0 |
| Mar 21, 2025 | Katzoff David J | Chief Financial Officer | Buy | 5,000 | $1.01 | $5.0K | 0 |
| Mar 20, 2025 | Horne William B. | Director | Buy | 5,000 | $0.98 | $4.9K | 0 |
| Mar 18, 2025 | AULT MILTON C III | Director | Buy | 5,000 | $0.96 | $4.8K | 0 |
| Mar 18, 2025 | Horne William B. | Director | Buy | 5,000 | $0.97 | $4.9K | 0 |
| Mar 12, 2025 | AULT MILTON C III | Director | Buy | 100 | $0.68 | $68.42 | 0 |
| Aug 6, 2024 | AULT MILTON C III | Director | Buy | 75 | $2.75 | $206.25 | 0 |
| Jul 31, 2024 | AULT MILTON C III | Director | Buy | 25 | $3.74 | $93.42 | 0 |
| Apr 19, 2024 | AULT MILTON C III | Director | Buy | 1,000 | $0.69 | $688.20 | 0 |
| Apr 1, 2024 | AULT MILTON C III | Director | Buy | 334 | $0.91 | $304.24 | 0 |
| Mar 28, 2024 | AULT MILTON C III | Director | Buy | 2,000 | $1.06 | $2.1K | 0 |
| Jan 5, 2024 | AULT MILTON C III | Director | Buy | 5,000 | $1.02 | $5.1K | 0 |
| Dec 22, 2023 | AULT MILTON C III | 10% Owner | Buy | 700 | $0.91 | $634.84 | 0 |
| Sep 26, 2023 | Katzoff David J | Chief Financial Officer | Buy | 53,000 | $0.19 | $10.2K1.7% OS | 0 |
| May 24, 2023 | AULT MILTON C III | 10% Owner | Buy | 18,000 | $0.59 | $10.7K0.6% OS | 0 |
| Apr 28, 2023 | Jackman Stephan | Chief Executive Officer | Buy | 37,000 | $0.54 | $20.0K1.2% OS | 0 |
| Mar 22, 2023 | McGrath Lynne Fahey | Director | Buy | 10,000 | $0.44 | $4.3K | 0 |
| Mar 16, 2023 | AULT MILTON C III | 10% Owner | Buy | 9,000 | $0.46 | $4.2K | 0 |
| Feb 15, 2023 | AULT MILTON C III | 10% Owner | Buy | 1,000 | $0.60 | $597.30 | 0 |
| Dec 27, 2022 | AULT MILTON C III | 10% Owner | Buy | 4,000 | $0.57 | $2.3K | 0 |
| Dec 21, 2022 | AULT MILTON C III | 10% Owner | Buy | 5,000 | $0.81 | $4.0K | 0 |
| Dec 16, 2022 | AULT MILTON C III | 10% Owner | Buy | 43,000 | $0.86 | $36.8K1.4% OS | 0 |
| Nov 18, 2022 | AULT MILTON C III | 10% Owner | Buy | 1,000 | $1.29 | $1.3K | 0 |
| Nov 2, 2022 | AULT MILTON C III | 10% Owner | Buy | 1,000 | $1.13 | $1.1K | 0 |
| Oct 31, 2022 | AULT MILTON C III | 10% Owner | Buy | 6,000 | $1.19 | $7.1K | 0 |
| Oct 12, 2022 | AULT MILTON C III | 10% Owner | Buy | 2,000 | $1.23 | $2.5K | 0 |
| Oct 6, 2022 | AULT MILTON C III | 10% Owner | Buy | 1,000 | $1.43 | $1.4K | 0 |
| Sep 29, 2022 | AULT MILTON C III | 10% Owner | Buy | 3,500 | $1.19 | $4.2K | 0 |
| Sep 19, 2022 | Jackman Stephan | Chief Executive Officer | Buy | 8,500 | $1.23 | $10.4K | 0 |
| Sep 14, 2022 | Katzoff David J | Chief Financial Officer | Buy | 10,000 | $1.11 | $11.1K | 0 |
| Aug 26, 2022 | AULT MILTON C III | 10% Owner | Buy | 9,100 | $0.94 | $8.6K | 0 |
| Aug 25, 2022 | AULT MILTON C III | 10% Owner | Buy | 4,900 | $0.96 | $4.7K | 0 |
| Aug 22, 2022 | AULT MILTON C III | 10% Owner | Buy | 36,000 | $0.97 | $34.9K1.1% OS | 0 |
| Aug 16, 2022 | AULT MILTON C III | 10% Owner | Buy | 15,000 | $1.08 | $16.2K | 0 |
Showing 1–50 of 108
1 / 3
ALZN Insider Buying Activity
The following table shows recent insider purchases of Alzamend Neuro, Inc. (ALZN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | AULT MILTON C III | director | Buy | 108,388 | $1.00 | $108.9K3.5% OS | 116,648New Position |
| Mar 26, 2025 | Horne William B. | Director | Buy | 3,334 | $0.99 | $3.3K | 0 |
| Mar 21, 2025 | AULT MILTON C III | Director | Buy | 2,905 | $1.02 | $3.0K | 0 |
| Mar 21, 2025 | Katzoff David J | Chief Financial Officer | Buy | 5,000 | $1.01 | $5.0K | 0 |
| Mar 20, 2025 | Horne William B. | Director | Buy | 5,000 | $0.98 | $4.9K | 0 |
| Mar 18, 2025 | AULT MILTON C III | Director | Buy | 5,000 | $0.96 | $4.8K | 0 |
| Mar 18, 2025 | Horne William B. | Director | Buy | 5,000 | $0.97 | $4.9K | 0 |
| Mar 12, 2025 | AULT MILTON C III | Director | Buy | 100 | $0.68 | $68.42 | 0 |
| Aug 6, 2024 | AULT MILTON C III | Director | Buy | 75 | $2.75 | $206.25 | 0 |
| Jul 31, 2024 | AULT MILTON C III | Director | Buy | 25 | $3.74 | $93.42 | 0 |
| Apr 19, 2024 | AULT MILTON C III | Director | Buy | 1,000 | $0.69 | $688.20 | 0 |
| Apr 1, 2024 | AULT MILTON C III | Director | Buy | 334 | $0.91 | $304.24 | 0 |
| Mar 28, 2024 | AULT MILTON C III | Director | Buy | 2,000 | $1.06 | $2.1K | 0 |
| Jan 5, 2024 | AULT MILTON C III | Director | Buy | 5,000 | $1.02 | $5.1K | 0 |
| Dec 22, 2023 | AULT MILTON C III | 10% Owner | Buy | 700 | $0.91 | $634.84 | 0 |
| Sep 26, 2023 | Katzoff David J | Chief Financial Officer | Buy | 53,000 | $0.19 | $10.2K1.7% OS | 0 |
| May 24, 2023 | AULT MILTON C III | 10% Owner | Buy | 18,000 | $0.59 | $10.7K0.6% OS | 0 |
| Apr 28, 2023 | Jackman Stephan | Chief Executive Officer | Buy | 37,000 | $0.54 | $20.0K1.2% OS | 0 |
| Mar 22, 2023 | McGrath Lynne Fahey | Director | Buy | 10,000 | $0.44 | $4.3K | 0 |
| Mar 16, 2023 | AULT MILTON C III | 10% Owner | Buy | 9,000 | $0.46 | $4.2K | 0 |
| Feb 15, 2023 | AULT MILTON C III | 10% Owner | Buy | 1,000 | $0.60 | $597.30 | 0 |
| Dec 27, 2022 | AULT MILTON C III | 10% Owner | Buy | 4,000 | $0.57 | $2.3K | 0 |
| Dec 21, 2022 | AULT MILTON C III | 10% Owner | Buy | 5,000 | $0.81 | $4.0K | 0 |
| Dec 16, 2022 | AULT MILTON C III | 10% Owner | Buy | 43,000 | $0.86 | $36.8K1.4% OS | 0 |
| Nov 18, 2022 | AULT MILTON C III | 10% Owner | Buy | 1,000 | $1.29 | $1.3K | 0 |
| Nov 2, 2022 | AULT MILTON C III | 10% Owner | Buy | 1,000 | $1.13 | $1.1K | 0 |
| Oct 31, 2022 | AULT MILTON C III | 10% Owner | Buy | 6,000 | $1.19 | $7.1K | 0 |
| Oct 12, 2022 | AULT MILTON C III | 10% Owner | Buy | 2,000 | $1.23 | $2.5K | 0 |
| Oct 6, 2022 | AULT MILTON C III | 10% Owner | Buy | 1,000 | $1.43 | $1.4K | 0 |
| Sep 29, 2022 | AULT MILTON C III | 10% Owner | Buy | 3,500 | $1.19 | $4.2K | 0 |
| Sep 19, 2022 | Jackman Stephan | Chief Executive Officer | Buy | 8,500 | $1.23 | $10.4K | 0 |
| Sep 14, 2022 | Katzoff David J | Chief Financial Officer | Buy | 10,000 | $1.11 | $11.1K | 0 |
| Aug 26, 2022 | AULT MILTON C III | 10% Owner | Buy | 9,100 | $0.94 | $8.6K | 0 |
| Aug 25, 2022 | AULT MILTON C III | 10% Owner | Buy | 4,900 | $0.96 | $4.7K | 0 |
| Aug 22, 2022 | AULT MILTON C III | 10% Owner | Buy | 36,000 | $0.97 | $34.9K1.1% OS | 0 |
| Aug 16, 2022 | AULT MILTON C III | 10% Owner | Buy | 15,000 | $1.08 | $16.2K | 0 |
ALZN Insider Selling Activity
The following table shows recent insider sales of Alzamend Neuro, Inc. (ALZN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | AULT MILTON C III | Director | Sell | 1,851 | $2.07 | $3.8K | 0 |
| Dec 19, 2025 | Horne William B. | Director | Sell | 3,333 | $2.12 | $7.1K | 0 |
| Oct 23, 2025 | McGrath Lynne Fahey | Director | Sell | 30 | $2.29 | $68.70 | 0 |
| Oct 8, 2025 | AULT MILTON C III | Director | Sell | 121,791 | $2.42 | $294.5K3.9% OS | 0 |
| Oct 3, 2025 | AULT MILTON C III | Director | Sell | 139,412 | $2.47 | $344.2K4.4% OS | 0 |
| Oct 1, 2025 | AULT MILTON C III | Director | Sell | 123,366 | $2.41 | $296.8K3.9% OS | 0 |
| Sep 26, 2025 | AULT MILTON C III | Director | Sell | 79,628 | $2.31 | $184.2K2.5% OS | 0 |
| Sep 23, 2025 | AULT MILTON C III | Director | Sell | 97,006 | $2.34 | $226.9K3.1% OS | 0 |
| Sep 19, 2025 | AULT MILTON C III | Director | Sell | 77,009 | $2.35 | $180.9K2.5% OS | 0 |
| Sep 17, 2025 | AULT MILTON C III | Director | Sell | 22,991 | $2.47 | $56.7K0.7% OS | 0 |
| Jul 30, 2025 | AULT MILTON C III | Director | Sell | 129,449 | $2.28 | $295.5K4.1% OS | 0 |
| Jul 25, 2025 | AULT MILTON C III | Director | Sell | 44,843 | $2.86 | $128.2K1.4% OS | 0 |
| Jul 23, 2025 | AULT MILTON C III | Director | Sell | 69,137 | $2.95 | $203.8K2.2% OS | 0 |
| May 12, 2025 | AULT MILTON C III | Director | Sell | 1,224 | $5.06 | $6.2K | 0 |
ALZN Insiders
Similar Stocks to ALZN
VRTX
Vertex Pharmaceuticals Incorporated
$423.11-1.53%
$109.41B
REGN
Regeneron Pharmaceuticals, Inc.
$685.00-6.30%
$76.03B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.67+0.59%
$40.31B
RVMD
Revolution Medicines, Inc.
$141.20-2.51%
$30.23B
INSM
Insmed Incorporated
$135.45+0.62%
$29.13B
UTHR
United Therapeutics Corporation
$572.36+0.68%
$25.13B
MRNA
Moderna, Inc.
$44.81-4.86%
$21.42B
RPRX
Royalty Pharma plc
$50.13+1.20%
$21.20B